Loading Events

Mental Health In Kidney Transplant Recipients

Thank you for attending, we hope you enjoyed this webinar.

Please tell us what you thought about today’s presentation by taking the survey below:

Mental Health In Kidney Transplant Recipients


Kidney transplantation offers patients with end-stage kidney (ESKD) disease freedom from frequent, time consuming, and uncomfortable dialysis treatments. However, successful outcomes are not ensured, and transplant recipients face new challenges, including concerns about transplant rejection and the need to adhere to a complex regimen of immunosuppressive therapy that may generate distressing side effects.1 Depression is a condition prevalent among patients with ESKD undergoing replacement therapy. It has also been increasingly recognized among kidney transplant recipients. It reduces self-esteem, leads to noncompliance with therapy, and eventually may lead to death.2

Did You Know?

  • In 2022, more than 25,000 kidney transplants were performed in a single year with 5,863 coming from living donors3
  • According to BDI, 22% – 39% of kidney transplant recipients reported depressive symptoms with 10% – 20% expressing moderate – severe depression1
  • Depression is associated with several identifiable factors and a 2-fold greater risk of graft failure and death with a functioning graft.1
Why Attend This Webinar?
  • Join us for this webinar to learn more about mental health in kidney transplant recipients and how it impacts patients, caregivers, graft survival, and mortality.
What You Will Learn  
  • The importance of mental health in kidney transplant recipients
  • The impact of untreated depression in kidney transplant recipients
  1. Dobbels et al. American Journal of Kidney Diseases. Vol 51(5) 2008:819-828.
  2. Rocha G et al. Transplantation Proceedings. Vol 33 2001: 3424

Fahad Aziz

Fahad Aziz, MD

Assistant Professor of Medicine – University of Wisconsin School of Medicine and Public Health Division of Nephrology – Transplant Medicine
Fahad Aziz, MD, FASN, is a faculty member in the Division of Nephrology within the Department of Medicine where he serves as the program director.

As a clinical nephrologist, Dr. Aziz cares for people living with a wide range of kidney diseases and disorders including renal transplant recipients. In addition to certification in the practice of internal medicine and nephrology, he holds Hypertension Specialist Certification from the American Society of Hypertension. Dr. Aziz is a member of the American College of Physicians, the American Society of Nephrology (ASN), and the American Society of Transplantation (AST). During his residency training, he was awarded “Best Resident of the Year” on two occasions. He has presented clinical research at national medical conferences at ASN and AST professional society scientific meetings. As a medical educator, he has provided classroom instruction topics in nephrology to physician assistant students and nephrology fellows as well as continuing medical education presentations to clinicians.

Lisa Voigt

Lisa Voigt, PharmD, BCPS, BCCCP

Nephrology Senior Medical Science Liaison

Otsuka Pharmaceutical Development & Commercialization, Inc.*

Lisa Voigt, PharmD, BCPS, BCCCP is a PharmD who works as a Senior Medical Science Liaison in Nephrology with Otsuka Pharmaceutical Development & Commercialization, Inc.  Prior to joining Otsuka in 2019, Dr Voigt practiced as a Medical Intensive Care Unit and Surgical Intensive Care Unit Pharmacist for 15 years at a tertiary medical center in Buffalo, NY.  She earned her Bachelor of Science degree in Pharmaceutics and PharmD from the SUNY Buffalo School of Pharmacy and Pharmaceutical Sciences.  She completed a Post-Graduate year 1 Pharmacy Residency and Post-Graduate year 2 Critical Care/Emergency Medicine Pharmacy Residency at the University of Rochester Medical Center in Rochester, NY. Dr Voigt is a Past-President of the New York State Council of Health-system Pharmacists and has served on the Board of Directors for the past 10 years. She is also Past-President of the Western New York Society of Health-system Pharmacists.  She is an Adjunct Assistant Professor at SUNY Buffalo, School of Pharmacy and Pharmaceutical Sciences.  Dr Voigt holds board certifications in pharmacotherapy as well as critical care pharmacotherapy.

Jaimini Patel

Jaimini Patel, PharmD, BCCCP

Nephrology Medical Science Liaison

Otsuka Pharmaceutical Development & Commercialization, Inc.*

Jaimini Patel, PharmD, BCCCP, is a Nephrology Medical Science Liaison at Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Dr Patel earned her Doctorate in Pharmacy from the University of Michigan, Ann Arbor and completed two years of post-doctoral residency at Beaumont Hospital, Royal Oak and Loyola University Medical Center, respectively, specializing in critical care pharmacy practice. Prior to joining Otsuka, Dr Patel practiced as a critical care pharmacist at the Cleveland Clinic Akron General Medical Center for 3.5 years and has cared for patients in the medical, surgical/trauma, cardiothoracic and neuroscience ICUs, and was significantly involved in the care of patients with COVID-19. Dr Patel holds board certification in critical care pharmacotherapy and is a licensed pharmacist in Michigan, Illinois and Ohio. She is also an active member of the Society of Critical Care Medicine through which she is engaged in research and leadership.

*Dr Fahad Aziz is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Drs Lisa Voigt & Jaimini Patel are employees of OPDC.


Related Resources

Join Today for Instant Access to all NephU Offerings.

Membership is free!

Join NephU today at no cost to register for this event and access to other premium content.

  • The NephU Community is collaborating to improve care and the future outcomes for individuals with kidney disease and other related conditions.
  • Quickly learn more about the topics that interest you.
  • Access our library of on-demand kidney health resources
  • Gain key insights from industry experts & though leaders.